GetTopicDetailResponse(id=071a118903bf, topicName=抗腫瘤免疫反應(yīng), introduction=, content=肝癌 抗腫瘤免疫反應(yīng), image=null, comments=0, allHits=592, url=null, type=1, isShow=1, status=1, isAdmin=null, adminId=5395722, adminEncryptionId=cade5395722, adminName=梅斯管理員, createdBy=cade5395722, createdName=梅斯管理員, createdAvatar=, createdTime=Mon Sep 09 17:28:36 CST 2024, time=2024-09-09, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=468563, tagList=[TagDto(tagId=468563, tagName=抗腫瘤免疫反應(yīng))], ipAttribution=上海, topicAdmin=0, lengthMark=0)
[GetTopicListResponse(id=2253972, encodeId=437d22539e282, content=<a href='/topic/show?id=8cdb1044e953' target=_blank style='color:#2F92EE;'>#銅死亡#</a> <a href='/topic/show?id=071a118903bf' target=_blank style='color:#2F92EE;'>#抗腫瘤免疫反應(yīng)#</a>, objectTitle=Small：重慶大學(xué)王槐志等團隊合作研究發(fā)現(xiàn)銅-錳基納米材料誘導(dǎo)銅死亡并增強抗腫瘤免疫反應(yīng), objectType=article, longId=864593, objectId=242286459354, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20250220/1740054122286_8538692.jpg, objectUrl=/article/show_article.do?id=242286459354, replyNumber=0, likeNumber=33, createdTime=2025-02-28, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陜西省, moduleDTOList=[ModuleDTO(moduleId=242286459354, moduleTitle=Small：重慶大學(xué)王槐志等團隊合作研究發(fā)現(xiàn)銅-錳基納米材料誘導(dǎo)銅死亡并增強抗腫瘤免疫反應(yīng), moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=242286459354)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2234511, encodeId=e55f223451199, content=<a href='/topic/show?id=071a118903bf' target=_blank style='color:#2F92EE;'>#抗腫瘤免疫反應(yīng)#</a> <a href='/topic/show?id=e3b11208e960' target=_blank style='color:#2F92EE;'>#Syndecan-1#</a>, objectTitle=Sci Adv：上海交通大學(xué)劉永忠團隊研究表明Syndecan-1抑制促進抗腫瘤免疫反應(yīng)并促進抗PD1檢查點免疫治療的療效, objectType=article, longId=849293, objectId=9dde849293ce, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/202401031/1730354068469_8538692.jpg, objectUrl=/article/show_article.do?id=9dde849293ce, replyNumber=0, likeNumber=44, createdTime=2024-11-01, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=9dde849293ce, moduleTitle=Sci Adv：上海交通大學(xué)劉永忠團隊研究表明Syndecan-1抑制促進抗腫瘤免疫反應(yīng)并促進抗PD1檢查點免疫治療的療效, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=9dde849293ce)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2224865, encodeId=030122248658f, content=<a href='/topic/show?id=370d8126914' target=_blank style='color:#2F92EE;'>#肝癌#</a> <a href='/topic/show?id=071a118903bf' target=_blank style='color:#2F92EE;'>#抗腫瘤免疫反應(yīng)#</a>, objectTitle=Mol Cancer：中山大學(xué)陳敏山等團隊合作發(fā)現(xiàn)肝細胞YTHDF2在肝臟中促進治療誘導(dǎo)的抗腫瘤免疫反應(yīng)的新作用, objectType=article, longId=842353, objectId=3c94842353d7, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240627/1719481658993_92910.png, objectUrl=/article/show_article.do?id=3c94842353d7, replyNumber=0, likeNumber=119, createdTime=2024-09-09, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=3c94842353d7, moduleTitle=Mol Cancer：中山大學(xué)陳敏山等團隊合作發(fā)現(xiàn)肝細胞YTHDF2在肝臟中促進治療誘導(dǎo)的抗腫瘤免疫反應(yīng)的新作用, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=3c94842353d7)], followStatus=false, userIsMember=false, type=null, lengthMark=0)]
梅斯管理員
2024-09-09發(fā)表于上海
